Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.

被引:8
作者
Moran-Gilad, J. [1 ]
Adler, A. [2 ]
Schwartz, D. [3 ]
Navon-Venezia, S. [2 ,4 ]
Carmeli, Y. [2 ]
机构
[1] Minist Hlth, Publ Hlth Serv, Jerusalem, Israel
[2] Minist Hlth, Natl Ctr Infect Control, Tel Aviv, Israel
[3] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Clin Microbiol Lab, IL-69978 Tel Aviv, Israel
[4] Ariel Univ, Dept Mol Biol, Ariel, Israel
关键词
BAUMANNII-CALCOACETICUS COMPLEX; CRITICALLY-ILL PATIENTS; CHROMAGAR ACINETOBACTER; SURVEILLANCE CULTURES; CARRIAGE;
D O I
10.1007/s10096-014-2159-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The optimal method for surveillance of carbapenem-resistant Acinetobacter spp. (CRAB) is unknown. A collection of CRAB strains (n = 42), carbapenem-susceptible strains (CSAB), and non-Acinetobacter strains (n = 18) was used to evaluate six laboratory surveillance methods: MacConkey (MAC), MAC + 1 mu g/ml imipenem (MAC-IPM), minimal salts agar + 1 % acetate (MSA), MSA with IPM disk (MSA-IPM), CHROMagarKPC, and CHROMagar Acinetobacter with CR102 (CHROMAcineto). CHROMAcineto was 100 % sensitive and specific. CHROMagarKPC and MAC-IPM were highly sensitive (> 95 %), but their specificity was substantially hampered by the breakthrough growth of CSAB. MSA was unsuitable for CRAB detection. CHROMAcineto is a promising medium for CRAB detection and warrants further clinical evaluation.
引用
收藏
页码:1909 / 1913
页数:5
相关论文
共 13 条
  • [11] Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii
    Marchaim, Dror
    Navon-Venezia, Shiri
    Schwartz, David
    Tarabeia, Jalal
    Fefer, Iris
    Schwaber, Mitchell J.
    Carmeli, Yehuda
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (05) : 1551 - 1555
  • [12] The CHROMagar Company, CHROMAGAR AC
  • [13] Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii
    Wareham, D. W.
    Gordon, N. C.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (02) : 164 - 167